49.51
Schlusskurs vom Vortag:
$48.06
Offen:
$48
24-Stunden-Volumen:
1.67M
Relative Volume:
1.18
Marktkapitalisierung:
$10.28B
Einnahmen:
$1.98B
Nettoeinkommen (Verlust:
$83.59M
KGV:
132.38
EPS:
0.374
Netto-Cashflow:
$502.31M
1W Leistung:
+4.34%
1M Leistung:
+5.88%
6M Leistung:
+1.87%
1J Leistung:
+13.69%
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QGEN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
QGEN
Qiagen Nv
|
49.51 | 10.28B | 1.98B | 83.59M | 502.31M | 0.374 |
![]()
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-24 | Eingeleitet | Barclays | Overweight |
2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
2021-10-15 | Fortgesetzt | Cowen | Market Perform |
2021-10-14 | Eingeleitet | Redburn | Buy |
2021-07-14 | Herabstufung | Kepler | Buy → Hold |
2021-06-03 | Eingeleitet | Goldman | Neutral |
2020-10-06 | Fortgesetzt | BofA Securities | Buy |
2020-09-28 | Hochstufung | Kepler | Hold → Buy |
2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
2020-01-07 | Eingeleitet | Citigroup | Neutral |
2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
2019-11-15 | Eingeleitet | Stifel | Hold |
2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
BlackRock’s Significant Stake in Qiagen Disclosed by AFM - TipRanks
Qiagen Announces Voting Rights Notification Involving BlackRock - TipRanks
QIAGEN launches long read sequencing panels for complex genomic analysis - StreetInsider
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - Business Wire
What drives Qiagen N.V. stock priceRapid wealth multiplication - jammulinksnews.com
Qiagen N.V. Stock Analysis and ForecastJaw-dropping returns - jammulinksnews.com
Qiagen NV stock reaches 52-week high at 48.91 USD - Investing.com India
Is Qiagen N.V. a good long term investmentExceptional return forecasts - jammulinksnews.com
What analysts say about Qiagen N.V. stockMassive wealth growth - Autocar Professional
Qiagen Announces Significant Voting Rights Notification by BlackRock - TipRanks
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - Yahoo Finance
Qiagen N.V. (NYSE:QGEN) is favoured by institutional owners who hold 79% of the company - simplywall.st
Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN
Qiagen and Gencurix partner for oncology tests - MSN
Qiagen NV stock hits 52-week high at 48.82 USD By Investing.com - Investing.com South Africa
QIAGEN Announces Managerial Share Transaction - TipRanks
Qiagen NV stock hits 52-week high at 48.82 USD - Investing.com Australia
QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast - Business Wire
QIAGEN NV : Deutsche Bank maintains a Buy rating - MarketScreener
QIAGEN Sets August 5 for Q2 2025 Earnings: Global Investors Briefing Across 3 Time Zones - Stock Titan
Baptista Research Begins Qiagen Coverage at Hold - MarketScreener
Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays - MSN
Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2031 - MarketScreener
Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2027 - MarketScreener
Qiagen N.V.(NYSE: QGEN) dropped from Russell 1000 Dynamic Index - MarketScreener
Ex-Dividend Reminder: Comcast, Qiagen and HA Sustainable Infrastructure Capital - Nasdaq
Qiagen Announces Managerial Share Transaction - TipRanks
Qiagen N.V. (QGEN) Expands MRD Testing with Tracer and Foresight Partnerships - MSN
QIAGEN Announces Election of Stephen Rusckowski as Chairman of S - GuruFocus
Qiagen (QGEN) Target Price Raised by B of A Securities | QGEN Stock News - GuruFocus
Qiagen stock reaches 52-week high at 48.24 USD - Investing.com
Barclays Starts Qiagen NV (QGEN) at Overweight - StreetInsider
Here's Why Qiagen (QGEN) is a Strong Value Stock - Nasdaq
Qiagen Announces BlackRock’s Significant Voting Rights Disclosure - TipRanks
Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo.co
Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions - MSN
QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership - BioSpace
Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics - MSN
Qiagen’s Voting Rights Notification Highlights BlackRock’s Influence - TipRanks
BlackRock’s Significant Stake in Qiagen Revealed - TipRanks
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):